Expert insights, guides, and stories about health The chasm between FDA clearance and sustainable Medicaid reimbursement for digital therapeutic platforms is vast, often proving a graveyard for promising innovations. While regulatory approval…
The promise of AI in healthcare often collides with the rigorous demands of value-based care (VBC). For health plan executives and investors navigating this complex…
Medicare Advantage (MA) plans operate within a complex financial ecosystem, where quality ratings directly translate into billions of dollars in bonus payments. For plan executives…
Health systems are getting squeezed, so when it comes to AI, the pressure is on to show real cost savings. Investors are done with the…
The Centers for Medicare & Medicaid Services (CMS) have, with the release of the Interoperability and Prior Authorization Final Rule (CMS-0057-F), irrevocably reshaped the operational…
Transitioning oncology to value-based care (VBC) models presents a formidable challenge, primarily due to the high costs associated with novel therapies and the inherent complexity…
Digital musculoskeletal (MSK) programs have proliferated, promising significant relief for a major category of employer health spend. Yet, the financial claims associated with these solutions…
The field of value-based care is rapidly evolving, and with it, the scrutiny applied to the economic claims of digital health platforms. Short-term pilot programs,…
The promise of AI in healthcare is vast, yet its true impact on value-based care (VBC) hinges not on ephemeral pilot results, but on demonstrable,…
The promise of artificial intelligence in healthcare is vast, offering pathways to improved outcomes and significant cost reductions. However, for employers and health plan executives…
